[
    [
        {
            "time": "",
            "original_text": "华熙生物(688363)：2020年收入增40%利润增10% 功能性护肤表现亮眼 组织机制持续升级",
            "features": {
                "keywords": [
                    "华熙生物",
                    "收入增长",
                    "利润增长",
                    "功能性护肤",
                    "组织机制升级"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "护肤"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物(688363)：2020年收入增40%利润增10% 功能性护肤表现亮眼 组织机制持续升级",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 6,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "医药投向标|福建第二轮集采纳入生物制品微医正式向港交所提交上市申请生物医药企业年报披露潮",
            "features": {
                "keywords": [
                    "医药",
                    "集采",
                    "生物制品",
                    "微医",
                    "上市申请",
                    "年报披露"
                ],
                "sentiment_score": 0.7,
                "policy_related": "true",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物医药",
                    "医疗健康"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "mixed"
            },
            "scores": {
                "News_content": "医药投向标|福建第二轮集采纳入生物制品微医正式向港交所提交上市申请生物医药企业年报披露潮",
                "Correlation": 6,
                "Sentiment": 5,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 8
            }
        }
    ]
]